Publications by authors named "Axel Guzman-Solis"

Humans have battled viruses for millennia. However, directly linking the symptomatology of disease outbreaks to specific viral pathogens was not possible until the twentieth century. With the advent of the genomic era and the development of advanced protocols for isolation, sequencing, and analysis of ancient nucleic acids from diverse human remains, the identification and characterization of ancient viruses became feasible.

View Article and Find Full Text PDF

After the European colonization of the Americas, there was a dramatic population collapse of the Indigenous inhabitants caused in part by the introduction of new pathogens. Although there is much speculation on the etiology of the Colonial epidemics, direct evidence for the presence of specific viruses during the Colonial era is lacking. To uncover the diversity of viral pathogens during this period, we designed an enrichment assay targeting ancient DNA (aDNA) from viruses of clinical importance and applied it to DNA extracts from individuals found in a Colonial hospital and a Colonial chapel (16th-18th century) where records suggest that victims of epidemics were buried during important outbreaks in Mexico City.

View Article and Find Full Text PDF
Article Synopsis
  • The 'red complex' is a group of three bacteria that cause serious gum disease.
  • Scientists found ancient DNA in teeth from people who lived in Mexico a long time ago, showing that certain bacteria were around since the first humans came to the Americas and changed when Europeans and Africans arrived.
  • The study helps us learn about how these bacteria affected humans over time and reveals important information about health in ancient Mexico.
View Article and Find Full Text PDF
Article Synopsis
  • A study assessed the antibody responses of 35 patients about a month after being infected with SARS-CoV-2.
  • * Patients with severe COVID-19 had significantly higher levels of antibodies targeting the viral nucleocapsid and spike proteins compared to those with milder cases.
  • * The research suggests that stronger immune responses in more severe cases could impact treatments like plasma therapy and the development of neutralizing monoclonal antibodies.*
View Article and Find Full Text PDF